nodes	percent_of_prediction	percent_of_DWPC	metapath
Masoprocol—IGF1R—brainstem—narcolepsy	0.0396	0.185	CbGeAlD
Masoprocol—IGF1R—forebrain—narcolepsy	0.0382	0.179	CbGeAlD
Masoprocol—CYP2J2—forebrain—narcolepsy	0.0259	0.121	CbGeAlD
Masoprocol—LTB4R—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0259	0.033	CbGpPWpGaD
Masoprocol—LTB4R—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0259	0.033	CbGpPWpGaD
Masoprocol—LTB4R—G alpha (q) signalling events—P2RY11—narcolepsy	0.025	0.0318	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0232	0.0295	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0232	0.0295	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0224	0.0285	CbGpPWpGaD
Masoprocol—LTB4R—G alpha (q) signalling events—HCRT—narcolepsy	0.0213	0.0271	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—TNFRSF1B—narcolepsy	0.0212	0.027	CbGpPWpGaD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.02	0.0255	CbGpPWpGaD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.02	0.0255	CbGpPWpGaD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0193	0.0246	CbGpPWpGaD
Masoprocol—LTB4R—brain—narcolepsy	0.0192	0.0899	CbGeAlD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.019	0.0242	CbGpPWpGaD
Masoprocol—CYP2J2—medulla oblongata—narcolepsy	0.0187	0.0875	CbGeAlD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0172	0.0218	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0172	0.0218	CbGpPWpGaD
Masoprocol—CYP2J2—midbrain—narcolepsy	0.0171	0.08	CbGeAlD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0166	0.0211	CbGpPWpGaD
Masoprocol—LTB4R—G alpha (q) signalling events—TRH—narcolepsy	0.0161	0.0205	CbGpPWpGaD
Masoprocol—IGF1R—brain—narcolepsy	0.0159	0.0742	CbGeAlD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.0144	0.0184	CbGpPWpGaD
Masoprocol—CYP19A1—forebrain—narcolepsy	0.0141	0.066	CbGeAlD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0141	0.0179	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—HCRTR2—narcolepsy	0.0131	0.0166	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—HCRTR1—narcolepsy	0.0131	0.0166	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—P2RY11—narcolepsy	0.0126	0.0161	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0126	0.016	CbGpPWpGaD
Masoprocol—LTB4R—G alpha (q) signalling events—TAC1—narcolepsy	0.0117	0.0149	CbGpPWpGaD
Masoprocol—LTB4R—G alpha (q) signalling events—NPS—narcolepsy	0.0117	0.0149	CbGpPWpGaD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.0109	0.0139	CbGpPWpGaD
Masoprocol—CYP2J2—brain—narcolepsy	0.0108	0.0503	CbGeAlD
Masoprocol—LTB4R—GPCR ligand binding—HCRT—narcolepsy	0.0107	0.0137	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.0107	0.0136	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.0105	0.0133	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.0105	0.0133	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—PENK—narcolepsy	0.00957	0.0122	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00937	0.0119	CbGpPWpGaD
Masoprocol—ALOX5—brain—narcolepsy	0.00847	0.0396	CbGeAlD
Masoprocol—LTB4R—GPCR ligand binding—TRH—narcolepsy	0.00813	0.0103	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00776	0.00987	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00776	0.00987	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00754	0.00959	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—HCRTR2—narcolepsy	0.00739	0.0094	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—HCRTR1—narcolepsy	0.00739	0.0094	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—P2RY11—narcolepsy	0.00713	0.00907	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—HRH3—narcolepsy	0.00713	0.00907	CbGpPWpGaD
Masoprocol—LTB4R—G alpha (q) signalling events—HTR2A—narcolepsy	0.00705	0.00897	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00672	0.00855	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—HCRTR2—narcolepsy	0.00671	0.00853	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—HCRTR1—narcolepsy	0.00671	0.00853	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—P2RY11—narcolepsy	0.00648	0.00824	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.0063	0.00802	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—HCRT—narcolepsy	0.00607	0.00772	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—NPS—narcolepsy	0.00591	0.00752	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—TAC1—narcolepsy	0.00591	0.00752	CbGpPWpGaD
Masoprocol—CYP19A1—brain—narcolepsy	0.00586	0.0274	CbGeAlD
Masoprocol—LTB4R—Signaling by GPCR—HCRT—narcolepsy	0.00551	0.00701	CbGpPWpGaD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00545	0.00693	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—PENK—narcolepsy	0.00541	0.00688	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00513	0.00652	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PENK—narcolepsy	0.00491	0.00625	CbGpPWpGaD
Masoprocol—IGF1R—Apoptosis—TNF—narcolepsy	0.00489	0.00622	CbGpPWpGaD
Masoprocol—IGF1R—MicroRNAs in cardiomyocyte hypertrophy—TNF—narcolepsy	0.00489	0.00622	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00467	0.00594	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—TRH—narcolepsy	0.0046	0.00585	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00457	0.00581	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—TNF—narcolepsy	0.00438	0.00557	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—TRH—narcolepsy	0.00417	0.00531	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—HRH3—narcolepsy	0.00403	0.00513	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HCRTR2—narcolepsy	0.00396	0.00504	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HCRTR1—narcolepsy	0.00396	0.00504	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—P2RY11—narcolepsy	0.00383	0.00487	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—HRH3—narcolepsy	0.00366	0.00466	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—HTR2A—narcolepsy	0.00356	0.00452	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00346	0.00441	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HCRTR2—narcolepsy	0.00337	0.00429	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HCRTR1—narcolepsy	0.00337	0.00429	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CHKB—narcolepsy	0.00336	0.00427	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—TAC1—narcolepsy	0.00334	0.00425	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—NPS—narcolepsy	0.00334	0.00425	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—P2RY11—narcolepsy	0.00325	0.00414	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HCRT—narcolepsy	0.00325	0.00414	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—TNF—narcolepsy	0.00308	0.00392	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—NPS—narcolepsy	0.00303	0.00386	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—TAC1—narcolepsy	0.00303	0.00386	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CHKB—narcolepsy	0.00299	0.00381	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PENK—narcolepsy	0.0029	0.00369	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HCRT—narcolepsy	0.00277	0.00352	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PENK—narcolepsy	0.00247	0.00314	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TRH—narcolepsy	0.00247	0.00314	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00235	0.00299	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CPT1B—narcolepsy	0.00228	0.0029	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HRH3—narcolepsy	0.00216	0.00275	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TRH—narcolepsy	0.0021	0.00267	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CPT1B—narcolepsy	0.00203	0.00259	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—HTR2A—narcolepsy	0.00201	0.00256	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HRH3—narcolepsy	0.00184	0.00234	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—HTR2A—narcolepsy	0.00182	0.00232	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TAC1—narcolepsy	0.00179	0.00228	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NPS—narcolepsy	0.00179	0.00228	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CHKB—narcolepsy	0.00154	0.00196	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TAC1—narcolepsy	0.00152	0.00194	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NPS—narcolepsy	0.00152	0.00194	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HTR2A—narcolepsy	0.00108	0.00137	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CPT1B—narcolepsy	0.00105	0.00133	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HTR2A—narcolepsy	0.000916	0.00117	CbGpPWpGaD
